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Background: Acinetobacter baumannii is an important nosocomial pathogen that poses a serious health threat to
immune-compromised patients. Due to its rapid ability to develop multidrug resistance (MDR), A. baumannii has
increasingly become a focus of attention worldwide. To better understand the genetic variation and antibiotic
resistance mechanisms of this bacterium at the genomic level, we reported high-quality draft genome sequences
of 8 clinical isolates with various sequence types and drug susceptibility profiles.
Results: We sequenced 7 MDR and 1 drug-sensitive clinical A. baumannii isolates and performed comparative
genomic analysis of these draft genomes with 16 A. baumannii complete genomes from GenBank. We found a high
degree of variation in A. baumannii, including single nucleotide polymorphisms (SNPs) and large DNA fragment
variations in the AbaR-like resistance island (RI) regions, the prophage and the type VI secretion system (T6SS). In
addition, we found several new AbaR-like RI regions with highly variable structures in our MDR strains. Interestingly,
we found a novel genomic island (designated as GIBJ4) in the drug-sensitive strain BJ4 carrying metal resistance
genes instead of antibiotic resistance genes inserted into the position where AbaR-like RIs commonly reside in other
A. baumannii strains. Furthermore, we showed that diverse antibiotic resistance determinants are present outside
the RIs in A. baumannii, including antibiotic resistance-gene bearing integrons, the blaOXA-23-containing transposon
Tn2009, and chromosomal intrinsic antibiotic resistance genes.
Conclusions: Our comparative genomic analysis revealed that extensive genomic variation exists in the A. baumannii
genome. Transposons, genomic islands and point mutations are the main contributors to the plasticity of the A.
baumannii genome and play critical roles in facilitating the development of antibiotic resistance in the clinical isolates.
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A. baumannii, an important nosocomial pathogen, is be-
coming an increasing threat to hospital patients due to its
ability to develop multidrug resistance (MDR) [1-3]. Drug
resistance in A. baumannii is due to a combination of
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unless otherwise stated.alteration of cell membrane impermeability, and increased
expression of efflux pumps [4]. The drug resistance genes
of A. baumannii isolates are often clustered into antibiotic
resistance islands (AbaRs) that interrupt the ATPase gene
(comM) [5]. For example, a 86-kb resistance island (RI)
was found in A. baumannii strain AYE (AbaR1) [6], and a
shorter RI was identified in the A. baumannii strain
ACICU (AbaR2) [7]. RIs are thought to emerge from the
integration of plasmids or other mobile elements, and
some drug-susceptible strains lack these RIs [6]. In
addition, plasmid-borne resistance genes have also been
reported, e.g., the blaOXA-23 gene, which is associated withs is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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baumannii isolates around the world [8,9].
Compared with current knowledge regarding antibiotic
resistance mechanisms in A. baumannii, less is known
regarding the virulence factors in this bacterium [10].
Several studies have focused on characterizing the forma-
tion of biofilms, one of the determinants involved in the
pathogenesis in A. baumannii. For example, a chaperone-
usher pili assembly system (csu locus) has been shown to
be involved in attachment and biofilm formation in A.
baumannii [11]. Other virulence factors identified include
a siderophore-mediated iron acquisition system, AbaI
autoinducer synthase, the BfmRS two-component regula-
tory system, the type VI secretion system (T6SS) [12] and
lipopolysaccharide (LPS) [13]. The LPS found in A. bau-
mannii, which is composed of lipids, O-antigen, and an
outer core (OC) and inner core, has been shown to be a
major contributor to the pathogenesis of infection [13].
The OC gene locus contains many genes encoding glyco-
syltransferase enzymes that catalyze the bonds between
sugars in the OC structure [14].
Whole-genome sequencing studies comparing distinct
drug-susceptible and MDR strains [1,15] or isolates from
a single patient [16] have improved our understanding
of the evolution of A. baumannii. To better understand
the genomic variation and the antibiotic resistance mecha-
nisms in A. baumannii, here we sequenced eight clinical
A. baumannii isolates with various sequence types and
drug susceptibility profiles and performed comparative
genomic analysis.
Results
Susceptibility profiles, multilocus sequence typing (MLST)
and whole-genome sequencing
The susceptibility profiles for all sequenced strains are
shown in Table 1. All 7 MDR strains were resistant toTable 1 Antimicrobial susceptibility profiles.R, resistant; I, int
Antimicrobial classes Antimicrobial drugs MIC (mg
BJ1
Aminoglycosides Gentamicin (CN) >8, R
Amikacin (AK) ≤16, S
Antipseudomonal carbapenems Imipenem (IPM) >8, R
Antipseudomonal fluoroquinolones Ciprofloxacin (CIP) >2, R
Lavo-ofloxacin (LEV) >4, R
Antipseudomonal penicillins and
β-lactamase inhibitors
Piperacillin-tazobactam (TZP) >64/4, R
Extended-spectrum cephalosporins Ceftriaxone (CTR) >32, R
Ceftazidime (CAZ) >16, R
Cefepime (FEP) >16, R
Polymyxins Polymyxin B (PB) ≤2, S
Tetracyclines Tetracycline (TE) =8, Ithe antibiotics gentamicin (CN), ciprofloxacin (CIP), cef-
triaxone (CTR), ceftazidime (CAZ), cefepime (FEP), and
tetracycline (TE) but susceptible to polymyxin B (PB).
The drug-sensitive strain BJ4 was sensitive or intermedi-
ate to all tested antibiotics except CTR.
We found that all 7 MDR strains correspond to global
clone II (GC II). The strains BJ2, BJ6, and BJ7 share the
same sequence type (ST), namely, ST208, and strains
BJ1 and BJ5 share a type (ST191). In addition, strains
BJ3 and BJ8 belong to ST218 and ST368, respectively.
However, the drug-sensitive strain BJ4 shows a novel se-
quence type.
The basic whole-genome sequencing statistics are shown
in Table 2. Illumina 100 bp paired-end sequencing pro-
duced more than 900 Mb of data for each of the eight
strains, and the sequencing depth ranged from 239× to
473×. The GC content of the genomes was approximately
38.9%, as expected for the species. The size of the genomes
varied from 3.86 to 4.03 Mb.Phylogenetic analysis of A. baumannii isolates
A maximum-likelihood tree of the 8 sequenced genomes
and 16 reported A. baumannii complete genomes were
created based on core SNPs from whole-genome align-
ment (Figure 1). The phylogenetic tree showed that the
previously sequenced strains and all of the 7 MDR clin-
ical isolates belonging to GC II formed a clade, while
strains AB307-0294, AYE, and AB0057, which belong to
GC I, grouped together. The BJ1 and BJ5 strains are
closely related, while strains BJ2, BJ6, and BJ7 form
another closely related group. Interestingly, strain BJ4,
the drug-sensitive strain, is distinct from all of the
sequenced MDR strains, which may indicate that it has
a unique origin compared with other drug-resistant
strains.ermediate; S, susceptible
/L) and Susceptibility
BJ2 BJ3 BJ4 BJ5 BJ6 BJ7 BJ8
>8, R >8, R ≤1, S >8, R >8, R >8, R >8, R
>32, R >32, R ≤2, S >32, R ≤16, S ≤16, S >32, R
>8, R >8, R ≤1, S >8, R >8, R >8, R ≤1, S
>2, R >2, R ≤0.25, S >2, R >2, R >2, R >2, R
>4, R >4, R ≤0.25, S >4, R >4, R >4, R =4, I
>64/4, R >64/4, R ≤4, I >64/4, R >64/4, R >64/4, R ≤16/4, S
>32, R >32, R 8, R >32, R >32, R >32, R >32, R
>16, R >16, R 4, I >16, R >16, R >16, R >16, R
>16, R >16, R 2, S >16, R >16, R >16, R >16, R
≤2, S ≤2, S ≤2, S ≤2, S ≤2, S ≤2, S ≤2, S
>8, R >8, R ≤4, S >8, R >8, R >8, R >8, R
Table 2 Sequencing statistics for the A. baumannii isolates
Strain Raw data (Mb) Sequencing depth (X) Scaffold number N50 length Mean length Max length Full length (bp) GC
BJ1 979 246 44 203665 90399 458403 3977574 38.9%
BJ2 959 239 52 164054 77219 364231 4015419 38.9%
BJ3 1540 390 35 236595 112903 460149 3951629 38.9%
BJ4 1666 420 54 150346 73375 433944 3962297 38.9%
BJ5 1895 473 47 211748 85260 458351 4007238 38.9%
BJ6 1079 268 56 133586 71990 364278 4031457 38.9%
BJ7 961 239 54 133586 74623 364278 4029682 38.9%
BJ8 1193 309 56 170785 68971 466960 3862420 39.0%
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We compared the gene contents of the 8 genomes with
other A. baumannii reference genomes using the PanOCT
analysis software [17], which utilizes conserved gene neigh-
borhood (CGN) and frameshift detection in a weighted
scoring scheme and the BLAST score ratio to effectively
generate non-paralogous gene clusters. We found that the
pan-genome continued to expand after the compilation
of 24 genomes, whereas the number of core genesFigure 1 Phylogenetic tree of A. baumannii isolates. A maximum
likelihood tree was constructed using dnaml from the PHYLIP
package, based on the core SNP in each genome. Bar, 0.01
substitution per nucleotide. “R” =multidrug resistance; “S” = drug-
sensitive; “UN” = unknown.remained relatively stable with the addition of new
strains (Figure 2A). The size of the pan-genome was
8245 genes, and there are 1902 genes (core) shared
among the 24 isolates (Figure 2B). The number of
unique genes ranges from 7 in strain BJ1 to 552 in strain
SDF (Table 3). Many of these unique genes are hypo-
thetical, transposon-related and phage-related genes.
Detailed information regarding orthologous groups and
singletons of the strains is provided in Additional file 1:
Table S1. The large number of unique genes in these
genomes likely indicates frequent horizontal gene trans-
fer events in A. baumannii. Hierarchical clustering of
these strains based on gene content yields a dendrogram
(Figure 2B) that is similar to the core SNP-based phylo-
genetic tree (Figure 1) in which strains from GC I form
one group and strains from GC II form another group.
We further analyzed the core and unique genes accord-
ing to the various classes of the Clusters of Orthologous
Groups (COGs) (Figure 2C). We found that core genes
were significantly enriched in genes belonging to class J
(Translation, ribosomal structure and biogenesis; P value =
1.53e-09) and class F (Nucleotide transport and metabol-
ism; P value = 0.0008301). In contrast, unique genes were
significantly enriched in class L (Replication, recombin-
ation and repair; P value < 2.2e-16), class V (Defense mech-
anisms; P value = 1.868e-09), and class M (Cell wall/
membrane/envelope biogenesis; P value = 0.0005701).
To compare protein sequence evolution rates between
the MDR isolates and the drug-sensitive isolates, we
measured the nonsynonymous substitution rate (Ka or
dN) in 1902 orthologous genes. We previously showed
that this rate is a relatively consistent parameter for de-
fining fast-evolving and slow-evolving protein-coding
genes [18]. The fast-evolving genes we identified among
the MDR isolates include many outer membrane pro-
teins and stress-related proteins; one of these proteins is
a phenazine biosynthetic PhzF-like protein that serves as
an enzyme essential for phenazine synthesis. Phenazines
are pigments, and many exhibit broad-spectrum anti-
biotic activity against bacteria, fungi, and parasites and
can contribute to the ecological competence of the
Figure 2 Analysis of the core and pan-genome of A. baumannii isolates. (A) Core and pan-genomic calculations in A. baumannii isolates.
Each green point represents the number of genes conserved between genomes. All of the points are plotted as a function of the strain number
(x). The deduced pan-genome size: P(x) = 972×0.54 + 2786.22. The height of the curve continues to increase because the pan-genome of A.
baumannii is open. (B). Genes missing or present in A. baumannii isolates. The heat map illustrates the distribution of core and accessory genes
across the A. baumannii strains. The columns represent A. baumannii isolates. The rows represent genes. The red and black regions represent the
presence or absence of genes in a particular genome, respectively. The black regions indicate features missing in that strain but present in one
or more of the other A. baumannii strains. (C). The distribution of all, core, and specific genes according to the COG classification. The y-axis
indicates the percentage of genes in various COG categories. (U) Intracellular trafficking and secretion; (V) Defense mechanisms; (D) Cell cycle
control, mitosis, and meiosis; (F) Nucleotide transport and metabolism; (O) Post-translational modification, protein turnover, chaperones; (O)
Posttranslational modification, protein turnover, chaperones; (J) Translation, ribosomal structure and biogenesis; (H) Coenzyme transport and
metabolism; (M) Cell wall/membrane/envelope biogenesis; (S) Function unknown; (K) Transcription; (P) Inorganic ion transport and metabolism;
(T) Signal transduction mechanisms; (G) Carbohydrate transport and metabolism; (N) Cell motility; (C) Energy production and conversion; (L)
Replication, recombination, and repair; (E) Amino acid transport and metabolism; (I) Lipid transport and metabolism; (R) General function
prediction only; (Q) Secondary metabolites biosynthesis, transport, and catabolism.
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genes include many conserved hypothetical proteins
and metabolism-related proteins. For example, SbmA,
which is involved in the prokaryotic internalization of
antimicrobial peptides (AMPs), was identified as a slow-
evolving gene [20].
SNPs among A. baumannii strains
The number of SNPs among the 7 MDR strains with
distinct STs ranged from 920 to 2675 (Additional file 2:
Table S2). The strains with the same STs showed fewer
SNPs, ranging from 74 to 196. Among the 74 putative
SNPs identified between BJ6 and BJ7, only 12 (16%) were
nonsynonymous mutations; these SNPs were locatedwithin genes coding for outer membrane receptor for
monomeric catechols, dihydropteroate synthase, fatty acid
desaturase, and a putative RND superfamily exporter. We
also found similar nonsynonymous mutations within all of
the genes mentioned above between BJ1 and BJ5.
To identify SNP regions clustered among the 7 MDR
strains, SNP density was estimated throughout the ge-
nomes using a sliding window of 5 kb. The resulting SNP
density map shows a non-random distribution, with many
regions having elevated SNP density (Additional file 3:
Figure S1). One large region of elevated SNP density is
around the origin of replication of the genome and the K
locus, as reported by Snitkin et al. [21]. We also found
other SNP clusters containing genes involved in heme
Table 3 Orthologous clusters in the A. baumannii
pan-genome
Strain Total Non-core % Non-core Unique % Unique
BJ1 3808 1906 50.1% 7 0.2%
BJ2 3846 1944 50.5% 32 0.8%
BJ3 3747 1845 49.2% 10 0.3%
BJ4 3767 1865 49.5% 408 10.8%
BJ5 3833 1931 50.4% 9 0.2%
BJ6 3870 1968 50.9% 8 0.2%
BJ7 3869 1967 50.8% 9 0.2%
BJ8 3651 1749 47.9% 27 0.7%
1656_2 3715 1813 48.8% 159 4.3%
AB0057 3790 1888 49.8% 182 4.8%
AB307_0294 3458 1556 45.0% 76 2.2%
ACICU 3667 1765 48.1% 70 1.9%
ATCC_17978 3787 1885 49.8% 507 13.4%
AYE 3607 1705 47.3% 183 5.1%
BJAB07104 3755 1853 49.3% 32 0.9%
BJAB0715 3848 1946 50.6% 247 6.4%
BJAB0868 3703 1801 48.6% 35 0.9%
D1279779 3388 1486 43.9% 105 3.1%
MDR_TJ 3704 1802 48.7% 28 0.8%
MDR_ZJ06 3860 1958 50.7% 58 1.5%
SDF 2913 1011 34.7% 552 18.9%
TCDC_AB0715 3851 1949 50.6% 178 4.6%
TYTH_1 3680 1778 48.3% 130 3.5%
ZW85_1 3465 1563 45.1% 136 3.9%
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type transport system, etc.
Virulence genes identified in the Virulence Factors
Database (VFDB)
Putative virulence genes were identified by aligning ORF
protein sequences to the virulence factors in the VFDB
(Additional file 4: Table S3). The homologs of clpP
(ATP-dependent Clp protease proteolytic subunit), aldA
(aldehyde dehydrogenase), xcpR (general secretion path-
way protein E), ureA (urease alpha subunit), tviB (Vi
polysaccharide biosynthesis protein), pilG (twitching
motility protein), pilH (twitching motility protein), htpB
(60 K heat shock protein), sodB (superoxide dismutase)
and manB (phosphomannomutase) were present in all
of the A. baumannii strains. The homologs of pilC, pilT,
and pilU were absent in SDF but present in the other
strains. In addition, the homologs of bplB (putative ace-
tyltransferase), VC0817 (putative transposase), SF2983
(transposase of Tn10) and katB (catalase-peroxidase)
were exclusively present in ATCC 17978, BJ4, AYE and
D1279779, respectively.Large genomic variants among A. baumannii strains
We compared the genomes of our 8 A. baumannii strains
with the reference genome of A. baumannii MDR-TJ, a
multidrug resistance strain belonging to GC II group [22].
We identified many highly variable regions (Figure 3); spe-
cifically, the following regions on the MDR-TJ genome are
missing or have low identity with our strains: from 982
to 1,034 kb, 1,343 to 1,363 kb, 1,364 to 1,400 kb, 1,575
to 1,617 kb, 2,460 to 2,500 kb, 3,672 to 3,710 kb and
3,798 to 3,894 kb.
The region from 982 to 1,034 kb was predicted to be
the prophage locus. The sequence of strain BJ1 in this
locus is highly similar to that of the reference genome,
while other strains have variable sequences in this region
(low protein identity or missing). Interestingly, an ISAba1-
associated deletion of approximately 20 kb in a region of
adhesion genes (csuE) from 1,343 to 1,363 kb was absent
from the strain BJ2 and from the previously reported ref-
erence strain MDR-ZJ06 [23]. The region from 1,364 to
1,400 kb encompasses a cluster of genes involved in iron
acquisition. The region from 1,575 to 1,617 kb was
predicted to be the second prophage locus. The approxi-
mately 40-bp region from 2,460 to 2,500 kb, which
encodes the entire type VI secretion system (T6SS), was
completely absent from strain BJ4. The region from 3,672
to 3,710 kb, which encodes the entire AbaR-like genomic
island (RIs), was also completely absent from strain BJ4. A
more detailed analysis of this island is shown in Figure 4.
The region from 3,798 to 3,894 kb contains many highly
divergent genes, including several membrane proteins,
stress-related proteins, and efflux pumps. Specifically, the
region from 3,869 to 3,894 kb encompasses a series of
genes encoding the O-antigen component of LPS.
In addition, the above-mentioned variable regions are
always accompanied by several insertion elements, which
may assist the integration of resistant and pathogenesis-
related genes and facilitate the transfer of drug resist-
ance and pathogenic genes among strains. In addition,
IS elements may enhance drug-resistance and virulence
by promoting gene expression [24,25]. Furthermore, the
CRISPR (clustered regularly interspaced short palindromic
repeats) systems, which were identified in the genomes of
three GC I strains (AYE, AB0057 and AB307-0294), were
not present in any of the 8 sequenced strains.
AbaR-like resistance islands (RIs)
We compared the sequences of AbaR-like RIs in each A.
baumannii isolate and found a series of variation events
at this locus (Figure 4). AbaR-like RIs inserted in the comM
gene were identified in all 7 MDR strains: AbaRBJ2 and
AbaRBJ3 shared the same structure, AbaRBJ6 and AbaRBJ7
shared a structure, and AbaRBJ1 and AbaRBJ5 shared a
structure. In addition, AbaRBJ8, AbaRBJ2 and AbaRBJ3 were
novel AbaR-like RIs, while the remaining regions have
Figure 3 ORF comparisons in A. baumannii genomes. Proteins from all sequenced 8 A. baumannii strains were aligned using MDR-TJ as a
reference. The tracks from inside to outside indicate the GC screw and GC content, and the circles from inside to outside are the BLASTP percent
identities of ORFs from BJ1 to BJ8 against MDR-TJ. Red indicates 90–100% identity, yellow indicates 60–89% identity, and blue indicates
0–59% identity.
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found in strain BJ4, which may partly explain its suscepti-
bility to antibiotics.
AbaRBJ8 shares the same backbone with AbaRMDR-TJ
and consists of two Tn6022 transposons and 3 resistance-
related regions (RR) (Figure 4). RR1a inserted at the 3’-
end of the island contains ISAba1Δ (mobile element), sul2
(conferring sulfonamide resistance), glmM (phosphogluco-
samine mutase) and tnsA (transposase protein A); RR2
located between the two copies of Tn6022 bears the anti-
biotic resistance gene sul2; RR3 at the 5’ end of AbaRBJ8
contains four resistance genes: tetA and tetR (conferring
tetracycline resistance), strA and strB (conferring strepto-
mycin resistance). There was also a cluster of ORFs
inserted between Tn6022 and RR2; this cluster is desig-
nated “ORFs” in Figure 4. Compared with AbaRBJ8, the
RR1a region and a part of the 3’end of Tn6022 in
AbaRMDR-TJ were absent. AbaRBJ2 and AbaRBJ3 had a
truncated RR1a (with a tnsAΔ) designated as RR1b; the
rest of the structure was identical to that of AbaRBJ8.
AbaRBJ6 and AbaRBJ7 included Tn6022Δ1 and RR3 seg-
ments, while AbaRBJ1 and AbaRBJ5 only contained the
Tn6022Δ1 segment without resistance genes.Comparative analysis of AbaR-like RIs in the 7 MDR
strains and the other 7 GC II isolates was also performed
(Figure 4). One major distinction among the RIs in the GC
II strains was the presence or absence of a second Tn6022
copy. Tn6022 or Tn6022Δ were mutual segments that
existed in all of these strains, while the three resistance re-
gions (RR1, RR2 and RR3) and ORFs were deleted or trun-
cated in certain strains. In AbaRBJAB0714, AbaRTCDC-AB0715
and AbaR1656–2, large fragments of inserted segments were
found: the vertical arrow in AbaRBJAB07104 indicates the in-
sertion of Tn6206 and the tra system specific to this island
[27]; the arrow in AbaR1656–2 indicates an inserted RR3a
segment containing the resistance genes per-1 and strA
(tnpA-tnpA2-gst-per-1-tnpA1-insB-IS3-strA) but not the
tetA(B) and tetR(B) regions of RR3 [28]; and the arrow in
AbaRTCDC-AB0715 indicates a large segment specific to this
strain containing six IS26 elements and multiple resistance
genes [29].
Interestingly, the comM region of the drug-sensitive
strain BJ4 was interrupted by a novel genome island (GI,
designated GIBJ4). This island was 29.3 kb in length and
contained no antibiotic resistance gene (Figure 5). Ra-
ther, five metal-resistance genes, including cueR, zntA,
Figure 4 Genetic structures of AbaR-like RIs in seven MDR strains and seven previously reported GC2 strains. Green rectangles indicate
resistance region RR1; red rectangles indicate resistance region RR2; grey rectangles indicate resistance region RR3; orange rectangles indicate
Tn6022 and Tn6022Δ; and blue rectangles indicate a cluster of orfs encoding proteins with unknown function. The dashed black lines denote
deletions. The vertical arrows in AbaRBJAB07104, AbaR1656–2 and AbaRTCDC-AB0715 indicate insertions of segments specific to these strains. RR1: tniC,
tniA, tniBΔ, ISAba1, sul2, glmM (phosphoglucosamine mutase), and tnsA (transposase protein A); RR2: tniCb, tniAb, tniBΔ2, ISAba1, sul2, and CRΔ;
RR3: tetA(B), tetR(B), CR (ISVsa3), strB, strA, and orf4b.
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Furthermore, 12 orfs of unknown function were present
in GIBJ4, including a tnsA gene encoding an endonucle-
ase domain protein, an int gene encoding an integrase
core domain protein, the transposon-related tniB and
tniQ genes and an inserted IS1236 segment.
Other mobile elements containing resistance genes
Class 1 integron is an important factor for the horizontal
transfer of resistance genes in A. baumannii, especiallyFigure 5 Structure of genomic islands in the BJ4 strain. The structure w
in the genome and showed that the comM gene was interrupted by a nov
length and did not contain any antibiotic resistance genes.the aminoglycoside resistance genes [30]. Six of our
MDR strains contained a class 1 integron, and their gene
cassette arrays were as follows: the integron of BJ1 har-
bored a gene cassette array of aacC1-orfP-orfP-orfQ-
aadA1; the integrons of BJ2, BJ6 and BJ7 included gene
a cassette array of aacC1-orfA-orfB-aadA1; and the
integrons of BJ3 and BJ5 had a gene cassette array of
aacA4-catB8-aadA1. Among these gene cassettes, aacC1,
aadA1 and aacA4 are aminoglycoside resistance genes;
catB8 is group B chloramphenicol acetyltransferase; andas drawn to scale according to the sequences of the genomic island
el genome island (designated as GIBJ4). This island was 29.3 kb in
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function. In addition, all of the found integrase protein se-
quences were 100% identical.
We also identified a blaOXA-23-containing transposon
Tn2009 in all sequenced strains, except for BJ4 and BJ8.
This result was consistent with the antimicrobial suscep-
tibility testing. Tn2009 has been previously described in
three Chinese A. baumannii strains: MDR-ZJ06, AB16
and MDR-TJ (in the pABTJ1plasmid) [22,23,30]. Genomic
analysis revealed that Tn2009 was flanked by two directed
repeats of ISAba1 elements at both ends, and the class D
β-lactamase gene blaOXA-23 existed at the 3’-end and was
adjacent to the ISAba1 element. IS elements represent an-
other source of variability among A. baumannii isolates,
and the insertion of ISAba1 might play a significant role
in the expression of blaOXA-23 [24,25].
Comparative analysis of antibiotic resistance genes
A comparative analysis of antibiotic resistance genes was
performed on the 8 sequenced strains and 16 reference
strains, among which the BJ4, D1279779, AB307-0294,
ATCC17978 and SDF strains are antibiotic susceptible
(Table 4). There are four types of β-lactamase in all of
these strains, including class A β-lactamase, class C
β-lactamase, class D β-lactamase and the metallo-β-
lactamase superfamily. The four types of β-lactamase
are encoded by various types of genes and are respon-
sible for much of the multidrug resistance of these
strains. Among the 8 sequenced strains in this study,
the ampC, metallo-β-lactamase superfamily gene, puta-
tive class A β-lactamase gene and blaOXA-66 existed in
all of the 7 MDR strains. The tem-1 and putative class C
β-lactamase gene were shared by six of the seven MDR
strains. However, per-1 is unique to BJ8, and blaOXA-69
is unique to BJ4. The per-1 gene also exists in MDR strain
1656–2. Per-1 is an extended-spectrum β-lactamase, and
its induction might be responsible for resistance to all
cephalosporins and cause difficulties in treating infec-
tions [31].
Resistance to aminoglycosides is primarily mediated by
aminoglycoside-modifying enzymes (AMEs), which in-
clude three types: aminoglycoside N-acetyltransferase,
aminoglycoside O-phosphotransferase, and aminoglyco-
side O-adenylyltransferase. These three types of AME
genes, especially the aacA4, aacC1, strA, strB, aphA1 and
aadA1 genes, are commonly found in the 7 sequenced
MDR BJ strains and the 12 reference MDR strains. In con-
trast, the sequenced non-MDR strain BJ4 and the 4 refer-
ence non-MDR strains contain fewer AMEs genes: BJ4,
D1279779, AB307-0294 and SDF each contain one aphA1-
gene, and ATCC17978 does not contain an AME gene.
Mutations in the gyrA (Ser83Leu) and parC (Ser80Ile)
genes are responsible for quinolone resistance in A. bau-
mannii. In this analysis, all of the MDR strains exceptZW85-1 contained a mutation in gyrA gene, while the
parC gene mutation was only present in nine of the MDR
strains. This result might indicate that gyrA (Ser83Leu)
plays a more important role than does parC (Ser80Ile) in
fluoroquinolone resistance. Among the 19 MDR strains,
only 10 include the group A or group B chloramphenicol
acetyltransferase genes. There may be other resistance
mechanisms, such as efflux pumps, that contribute to
chloramphenicol resistance in these MDR strains. The
sulfonamide-resistant dihydropteroate synthase genes were
present in all of the analyzed MDR strains, while in the 5
non-MDR strains, only ATCC17978 contained a sul2 gene.
The RND (resistance-nodulation-division) family efflux
pump, consisting of the adeA, adeB and adeC genes,
was present in most of these strains. This efflux pump
requires the coexistence of all three genes (adeA, adeB
and adeC) to function properly. The antibiotic-susceptible
strains D1279779, ATCC17978 and SDF do not contain a
functional AdeABC efflux pump. All of the MDR strains
except BJAB0715 contain intact adeA, adeB and adeC
genes, which might play a role in their antibiotic resist-
ance. Some efflux pump genes belonging to the MFS
(major facilitator superfamily) were also identified in sev-
eral of the MDR strains, including tetA, tetB and tetG,
which encode tetracycline efflux proteins, and cmlA and
cmlA5, which encode chloramphenicol efflux proteins.
Discussion
In this study, we used whole-genome sequencing methods
to characterize genomic variations and antibiotic resist-
ance mechanisms in clinical A. baumannii isolates with
various sequence types and drug susceptibility profiles. Al-
though the isolates are closely related, we identified sig-
nificant genetic differences and a high degree of genomic
plasticity in these strains. Pan-genomic analysis of the 8 A.
baumannii isolates and the other 16 complete genomes
revealed that A. baumannii genomes were highly hetero-
geneous with respect to gene content and possessed a
series of unique genes; these results are similar to those of
previous studies [15,32]. The unique genes are enriched in
COG class L (Replication, recombination and repair), class
V (Defense mechanisms), and class M (Cell wall/mem-
brane/envelope biogenesis), which suggests that these
genes are critical for A. baumannii survival or are closely
associated with the ability of the bacteria to adapt to chal-
lenging niches.
Phylogenetic analysis showed that the drug-susceptible
isolate BJ4 was distinct from the other MDR strains, and
its closer relationship with the AB0057 and AYE MDR
isolates offers another perspective on the origins and ac-
quisition of antibiotic resistance determinants. In addition,
the close relationship among strains BJ2, BJ6, and BJ7 in-
dicated they these strains may come from a common an-
cestor. The csuE deletion in strain BJ2 suggested that this
Table 4 Antimicrobial resistance-associated genes in the 8 BJ strains and 16 reference strains. 0 = absent, 1 = present,
1R = present and resistant (bearing a point mutation), 1S = present but sensitive (no point mutation)
Drug class Enzyme class, description Coding
gene
BJ1 BJ2 BJ3 BJ4 BJ5 BJ6 BJ7 BJ8 AYE ACICU TYTH-1 AB0715
β-Lactamases class A β-lactamase tem-1 1 1 0 0 1 1 1 1 0 0 0 1
per-1 0 0 0 0 0 0 0 1 0 0 0 0
veb 0 0 0 0 0 0 0 0 1 0 0 0
putative class A β-lactamase 1 1 1 0 1 1 1 1 0 1 1 1
class C β-lactamase ampC 1 1 1 1 1 2 1 1 1 3 1 2
putative class C β-lactamase 1 1 1 1 1 0 1 1 0 0 1 0
class D β-lactamase blaOXA-23 1 1 1 0 1 1 1 0 0 0 0 1
blaOXA-66 1 1 1 0 1 1 1 1 0 1 0 1
blaOXA-69 0 0 0 1 0 0 0 0 1 0 0 0
blaOXA-10 0 0 0 0 0 0 0 0 1 0 0 0
blaOXA-90 0 0 0 0 0 0 0 0 0 0 0 0
blaOXA-109 0 0 0 0 0 0 0 0 0 0 0 0
metallo-β-lactamase superfamily 2 2 1 1 2 2 2 2 1 1 0 2
Aminoglycosides aminoglycoside N-acetyltransferase aacA4 0 0 1 0 1 0 0 0 0 1 1 1
aacC1 1 1 0 0 0 1 1 0 1 0 0 1
aac3iia 0 0 0 0 0 0 0 0 0 0 0 0
aminoglycoside O-phosphotransferase strA 0 1 1 0 0 1 1 1 1 0 1 1
strB 0 1 1 0 0 1 1 1 1 0 1 1
aphA1 0 1 1 1 0 1 1 1 2 1 1 3
aph3via 0 0 0 0 0 0 0 0 0 0 0 0
aminoglycoside O-adenylyltransferase aadA1 1 1 1 0 1 1 1 0 2 0 1 2
ant2ia 0 0 0 0 0 0 0 0 1 0 0 0
Chloramphenicol group A chloramphenicol
acetyltransferase
catA1 0 0 0 0 0 0 0 0 1 0 0 0
group B chloramphenicol
acetyltransferase
catB8 0 0 1 0 1 0 0 0 0 0 0 0
catB3 0 0 0 0 0 0 0 0 0 0 1 1
Sulfonamides sulfonamide-resistant dihydropteroate
synthase
sul1 1 1 1 0 1 1 1 1 3 1 1 2
sul2 0 1 1 0 0 0 0 1 0 0 1 1
Fluoroquinolones gyrA mutation (Ser-83→ Leu) gyrA 1R 1R 1R 1S 1R 1R 1R 1R 1R 1R 1R 1R
parC mutation (Ser-80→ Ile) parC 1R 1R 1R 1S 1R 1R 1R 1S 1R 1S 1S 1R
Efflux pumps MFS (major facilitator superfamily)
family
tetA 0 1 1 0 0 1 1 0 1 0 0 0
tetB 0 0 0 0 0 0 0 0 0 0 1 1
tetG 0 0 0 0 0 0 0 0 1 0 0 0
cmlA 0 0 0 0 0 0 0 0 1 0 0 0
cmlA5 0 0 0 0 0 0 0 0 1 0 0 0
RND (resistance-nodulation-division)
family
adeA 1 1 1 1 1 1 1 1 1 1 1 1
adeB 1 1 1 1 1 1 1 1 1 1 1 1
adeC 1 1 1 1 1 1 1 1 1 1 1 1
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BJAB07104 BJAB0868 BJAB0715 SDF
β-Lactamases 0 0 0 1 0 0 0 0 0 1 0 0
1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 1 0 1 1 1 1 1 1 0
2 0 1 2 1 1 4 2 3 3 2 0
0 0 0 0 0 0 0 0 0 0 1 0
0 0 0 1 0 0 1 1 1 1 1 0
0 0 0 0 0 0 1 1 1 1 0 0
0 0 0 1 1 0 0 0 0 0 0 0
0 0 0 0 1 0 0 0 0 0 0 0
0 1 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0
0 4 5 5 7 1 2 1 1 1 0 0
Aminoglycosides 0 0 0 0 0 0 1 1 1 1 0 0
1 0 0 1 0 0 1 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0
2 0 0 0 0 0 1 1 1 1 1 0
1 0 0 0 0 0 1 1 1 1 1 0
1 1 1 2 1 0 1 2 2 2 0 1
0 1 0 0 0 0 0 0 0 0 1 0
2 0 0 1 0 0 2 2 1 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0
Chloramphenicol 0 0 0 1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 1 0 0 0 0
0 0 0 0 0 0 1 1 1 1 0 0
Sulfonamides 1 0 0 2 0 0 2 2 1 1 0 0
1 1 0 0 0 1 1 0 1 1 1 0
Fluoroquinolones 1R 1S 1S 1R 1R 1S 1R 1R 1R 1R 1R 1S
1S 1S 1S 1R 1S 1S 1S 1S 1S 1S 1S 1S
Efflux pumps 0 0 0 1 0 0 0 0 0 0 0 0
0 1 0 0 0 0 1 1 1 1 1 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
1 1 1 1 1 2 1 1 1 1 0 0
1 1 1 1 1 1 1 1 1 1 0 0
1 0 0 1 1 0 1 1 1 1 0 0
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http://www.biomedcentral.com/1471-2164/15/1163loss may have occurred after the ancestral strain entered
the hospital, followed by the mixing of strains with and
without csuE.
A comparison of the gene content-based dendrogram
with the core SNP tree revealed a similar clustering rela-
tionship. The slight difference in tree topology is primar-
ily driven by (i) lateral gene transfer and (ii) IS-mediated
phage- and plasmid-associated gene gain and loss. The
CRISPR repeat elements, which are involved in a com-
plex mechanism that inhibits invasive phage and plasmid
DNA, were not present in any of the eight strains, which
may partly explain the widespread distribution of phage-
and plasmid-related genes and the extensive genomic
plasticity among A. baumannii isolates.
Many regions associated with IS-mediated deletions,
including a deletion of the entire T6SS region, have been
shown to be involved in interbacterial interactions [12].
We found that the T6SS region is conserved in all 7 of
the analyzed MDR A. baumannii isolates. As antibiotic
therapy appears to reduce interbacterial competition,
this result is consistent with the hypothesis that the
MDR phenotype is conferred by antibiotic resistance
genes, indicating that the T6SS regions are less import-
ant [33]. The surface polysaccharide loci are highly vari-
able among the 8 strains, which is consistent with a
previous report that these regions are significant sources
of variability within A. baumannii strains [14]. We also
found that the OC locus (from 558 to 566 kb in Figure 3)
was less variable and was highly conserved among the
MDR strains, but this region was almost completely
missing from the drug-sensitive strain BJ4. In addition,
virulence gene analysis showed that a total of 10 putative
virulence genes were present in all A. baumannii ge-
nomes, suggesting that these genes may play significant
roles in the pathogenesis of A. baumannii infection.
AbaR-like RIs inserted in the comM gene were identified
in all 7 of the analyzed MDR strains but not in the drug-
sensitive strain BJ4. This isolate contained a 29.3-kb new
GI with five metal-resistance genes but no antibiotic
resistance genes (Figure 5). Therefore, we suggested that
GIs inserted into the comM gene are not always associated
with antibiotic resistance, and their function might be re-
lated to the adaption of the strain to its survival niche. We
also found that the RI is highly variable in composition
and is not the only contributor to the MDR phenotype.
Resistance genes in other mobile elements are found out-
side the RIs, and they are able to contribute to drug resist-
ance in each strain examined. Among the seven MDR
strains, only strain BJ8 did not contain the blaOXA-23-con-
taining transposon Tn2009, suggesting that Tn2009 is an
important carrier of the blaOXA-23 gene in clinical isolates.
Furthermore, the detection of Tn2009 in both chromo-
some and plasmid DNA suggested that this transposon
can be transferred easily between clinical strains.Antimicrobial susceptibility testing indicated that, com-
pared with the 7 MDR strains, the drug-sensitive strain
BJ4 shows low-level resistance to piperacillin-tazobactam
(TZP), ceftriaxone (CTR) and ceftazidime (CAZ). We
hypothesize that this type of low-level resistance is likely
caused by the four β-lactamase genes carried by this strain
(Table 4). In addition, the aphA1 gene identified in BJ4 en-
codes resistance to kanamycin but not to gentamicin, ami-
kacin or netilmicin [34]. This result may explain why this
strain is susceptible to gentamicin and amikacin. The class
D β-lactamase gene blaOXA-69 is unique to strain BJ4,
while the 7 MDR strains contain a blaOXA-66 gene at the
same genomic location. The intrinsic blaOXA-69 gene en-
codes oxacillinase, which can hydrolyze imipenem and
meropenem at a low level [35]. It is reported that the pres-
ence of IS elements such as ISAba1 in the upstream of
blaOXA-69 can up-regulate the resistance gene’s expression
level [25,36]; however, few IS elements were found in the
drug-sensitive strain BJ4, and no IS elements are present
upstream of the intrinsic resistance genes. In contrast, the
MDR strains contain a series of IS element copies, includ-
ing ISAba1, ISAba125, and IS26; importantly, ISAba1 ele-
ments were identified upstream of blaOXA-23 and other RIs
in all MDR strains. These results may partly explain the
variations in antimicrobial susceptibility between the
MDR strains and the sensitive strain.
SNPs are another important source of genetic vari-
ation and may contribute to drug resistance and patho-
genesis in A. baumannii [37]. Both phylogenic and SNP
analysis indicated that the drug-sensitive isolate BJ04 is
genetically distinct from other MDR A. baumannii strains.
In addition, only a small proportion of SNPs are nonsynon-
ymous among closely related clinical MDR A. baumannii
strains with the same STs, indicating that these strains may
undergo purifying selection on a genome-wide scale. Fur-
thermore, mutation hotspots between MDR strains were
identified in several genes associated with drug resistance,
e.g., genes encoding dihydropteroate synthase, a target for
sulfonamide antibiotics, and the putative RND superfamily
exporter genes, which encode multidrug efflux pumps [38].
Conclusions
In this study, we used whole-genome sequencing to
identify genetic variants in A. baumannii isolates. We
performed comparative genomic analysis of 8 clinical A.
baumannii isolates with 16 available complete A. bau-
mannii genomes in the NCBI database. Our results shed
new light on the importance of genomic variations,
especially transposon-related and/or phage-related gene
variations, in the evolution of A. baumannii. Further-
more, we suggest that the MDR A. baumannii strains
harbor diverse antibiotic resistance mechanisms. Future
studies focused on a larger sample of A. baumannii iso-
lates from various hospitals and lineages are necessary to
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Methods
Bacterial isolates and antimicrobial susceptibility testing
The A. baumannii strains BJ1 to BJ8 were isolated from
the 306th Hospital of People’s Liberation Army in Beijing,
China. Identification of the isolates and antimicrobial sus-
ceptibility testing were performed using the bioMérieux
VITEK-2 AST-GN13 system following the manufacturer’s
instructions. The minimum inhibitory concentration (MIC)
of 11 antimicrobial agents was determined according to the
recommendations given by the Clinical and Laboratory
Standards Institute (CLSI) (Clinical and Laboratory Stan-
dards Institute, 2011) [1]. The reference strains Escherichia
coli ATCC 25922 and Pseudomonas aeruginosa ATCC
27853 were used as quality controls.
DNA extraction, whole-genome sequencing, and
annotation
Genomic DNA was extracted using the TIANamp bac-
teria DNA kit (Tiangen Biotech (Beijing) Co., Ltd.) ac-
cording to the manufacturer’s instructions. The genomic
DNA was fragmented by ultrasonication, and the DNA
fragments were subjected to the whole-genome sequen-
cing workflow of the Illumina HiSeq 2000 system. Gen-
ome assembly was carried out by SOAPdenovo (http://
soap.genomics.org.cn). The detailed methods for genome
assembly and annotation were described in another study
[39]. To close gaps within the AbaR-like RIs and inte-
grons, primer pairs were designed at the end of each gap
using the genomes as templates. The PCR products were
sequenced with an ABI 3730 automated DNA sequencer,
and the sequences of these products were used to fill the
gaps. Random primers within the AbaR-like RIs and inte-
gron regions were subsequently designed to reconfirm the
accuracy of these sequences.
Multiple locus sequence typing (MLST)
To identify sequence types, we aligned the assembled se-
quences against seven housekeeping gene sequences (gltA,
gyrB, gdhB, recA, cpn60, gpi, and rpoD) using BLAST and
then extracted the aligned sequences by comparing them
to allele profiles in the A. baumannii MLST database
(http://pubmlst.org/).
SNP detection and analysis
The short reads were first aligned onto the MDR-TJ gen-
ome reference using the SOAP2 program [40]. Then,
SOAPsnp was used to score SNPs from aligned reads
[41]. The SOAPsnp results were filtered as follows: 1)
the read coverage of the SNP site was greater than five;
2) the Illumina quality score of either allele was greater
than 30; and 3) the count of the all of the mapped bestbase was more than twice the count of all of the mapped
second best base. From all of the SNPs identified in the
sequenced genome sequences, the SNP density was cal-
culated throughout the MDR-TJ genome using a sliding-
window size of 5 kb. This window was moved at steps of
1 kb at a time, and the SNP number within each window
size was counted. The construction of an SNP clustering
map was performed using Circos [42].
Comparative genomics analysis
Genomic data used in comparative analysis were down-
loaded from the NCBI ftp server, including complete
genome sequences of A. baumannii isolates MDR-ZJ06
(CP001937.1), MDR-TJ (CP003500.1), BJAB0715 (CP0
03847.1), AB1656-2 (CP001921.1), AB0057 (CP0011
82.1), AB307-0294 (CP001172.1), ACICU (CP000863.1),
ATCC 17978 (CP000521.1), AYE (CU459141.1), BJAB
07104 (CP003846.1), BJAB0868 (CP003849.1), D1279
779 (CP003967.1), TCDC-AB0715 (CP002522.2), TY
TH-1 (CP003856.1), ZW85-1 (CP006768.1), SDF (CU4
68230), and ADP1 (NC_005966.1).
Multiple sequence alignments of the A. baumannii ge-
nomes were performed with Mugsy [43]. The phylogen-
etic tree was constructed using dnaml from the PHYLIP
package [44] based on SNPs from the whole-genome
alignment, and the genome of Acinetobacter sp. ADP1
was used as the outgroup. An all-against-all BLASTP
search between every pair of protein sequences from
each strain was performed. Orthologs were identified
using PanOCT [17] with the BLASTP output (Identity
80%; Aligned length 30%; E-value < 1e−5). The map for
core and pan-genome calculations in A. baumannii
isolates was performed using PanGP [45]. The heatmap
figure was generated using the R package pheatmap [46].
The map of ORF comparisons among A. baumannii ge-
nomes was constructed using Circos [42]. As shown in
the phylogenetic analysis, the strain SDF was genetically
the most distant from our strains; this strain is therefore
more suitable for analyzing the nonsynonymous substitu-
tion rate and thereby defining the rapidly and slowly
evolving protein-coding genes. We aligned the amino acid
sequences of SDF with our sequenced strains, estimating
the nonsynonymous substitution rates of orthologs based
on the NG method using KaKs_Calculator 2.0 [47].
COG annotation was performed using the BLAST
software against the COG database. COG enrichment
analysis was determined using Fisher’s exact test by
comparing the prevalence of a target group of genes
assigned to a specific COG category to the prevalence of
genes in the whole genome assigned to that COG cat-
egory. To identify possible virulence factors, the Virulence
Factors Database (VFDB) [48] was aligned to the ORF
protein sequences and filtered with 60% identity and 90%
aligned length. To search the antibiotic resistance genes,
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Antibiotic Resistance Database (ARDB) [49,50] using the
similarity thresholds recommended in ARDB. PHAST
[51] was used to identify the putative prophages in Aci-
netobacter genomes. ISs were identified using the IS
Finder database (www-is.biotoul.fr) [52]. The detection
of CRISPR loci in 8 sequenced draft genome sequences
was performed using CRISPRFinder [42].Nucleotide Sequence Accession Numbers
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